PNC Financial Services Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Buy |
|
|||||
|
2025
Q1 | $4.23K | Sell |
|
|||||
|
2024
Q4 | $3.89K | Sell |
|
|||||
|
2024
Q3 | $6.33K | Buy |
|
|||||
|
2024
Q2 | $4.14K | Sell |
|
|||||
|
2024
Q1 | $13.6K | Sell |
|
|||||
|
2023
Q4 | $21.2K | Sell |
|
|||||
|
2023
Q3 | $20.6K | Buy |
|
|||||
|
2023
Q2 | $17.4K | Buy |
|
|||||
|
2023
Q1 | $15.2K | Hold |
|
|||||
|
2022
Q4 | $13.8K | Hold |
|
|||||
|
2022
Q3 | $14K | Sell |
|
|||||
|
2022
Q2 | $12K | Sell |
|
|||||
|
2022
Q1 | $22K | Sell |
|
|||||
|
2021
Q4 | $36K | Buy |
|
|||||
|
2021
Q3 | $34K | Sell |
|
|||||
|
2021
Q2 | $61K | Sell |
|
|||||
|
2021
Q1 | $80K | Buy |
|
|||||
|
2020
Q4 | $74K | Buy |
|
|||||
|
2020
Q3 | $50K | Buy |
|
|||||
|
2020
Q2 | $32K | Buy |
|
|||||
|
2020
Q1 | $21K | Buy |
|
|||||
|
2019
Q4 | $24K | Sell |
|
|||||
|
2019
Q3 | $98K | Buy |
|
|||||
|
2019
Q2 | $78K | Sell |
|
|||||
|
2019
Q1 | $88K | Buy |
|
|||||
|
2018
Q4 | $5K | Sell |
|
|||||
|
2018
Q3 | $9K | Buy |
|
|||||
|
2018
Q2 | $6K | Buy |
|
|||||
|
2018
Q1 | $4K | Buy |
|
|||||
|
2017
Q4 | $2K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $2K | Sell |
|
|||||
|
2016
Q1 | $3K | Sell |
|
|||||
|
2015
Q4 | $11K | Buy |
|
|||||
|
2015
Q3 | $7K | Sell |
|
|||||
|
2015
Q2 | $16K | Buy |
|
|||||
|
2015
Q1 | $9K | Buy |
|